Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Catherine Le Berre, Laurent Peyrin-Biroulet, SPIRIT-IOIBD study group, Pia Susanne Munkholm (Member of study group)

96 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology